Best Practices and Research Advances in Thoracic Oncology: A Regional Series MENA Course 1: Liquid Biopsy in Lung Cancer-The Emerging Liquid Biopsy Technology Landscape (Liquid Biopsy in the Region)

The Emerging Liquid Biopsy Technology Landscape (Liquid Biopsy in the Region)

Video Transcription

Video Summary

Dr. Arifat Tifaili, a medical oncologist, discusses the role of liquid biopsy in cancer treatment, primarily lung cancer. Unlike traditional biopsies, which involve tissue sampling, liquid biopsy uses body fluids like blood to detect circulating tumor cells and DNA. It offers a less invasive, safer alternative that can more accurately capture tumor heterogeneity over time. Despite limitations such as varying sensitivity and inability to replace solid biopsies for initial cancer diagnosis, liquid biopsy promises better tracking of tumor evolution and response to therapy. It's particularly useful for identifying genetic mutations for targeted treatment, with ongoing research on its role in early cancer detection. Currently, these assays are limited but expanding, with some tests available in the Middle East and North Africa, where access is generally restricted. Dr. Tifaili emphasizes the need for larger studies to validate its routine clinical use and impact on treatment outcomes.

Asset Subtitle

Arafat Tfayli, MD

Meta Tag

Concept Liquid Biopsy

Concept Circulating Tumor Cells

Concept Circulating Tumor DNA

Concept Mutation Detection

Concept Solid Biopsy

Keywords

liquid biopsy

cancer treatment

tumor heterogeneity

genetic mutations

Dr. Arifat Tifaili

Liquid Biopsy

Circulating Tumor Cells

Circulating Tumor DNA

Mutation Detection

Solid Biopsy